Home > Publishers > GervanoRA Data Services LLP
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Publisher
Filter

GervanoRA Data Services LLP Report List

gerv
GervanoRA Data Services LLP is a premier provider of syndicated research reports, custom research reports and consulting services, based in Goa, India. GDS aims to deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial views of the competitive framework, and future market trends. We continuously strive to be ahead of our competitors by providing unique competitive analytics like pipeline analysis reports, Epidemiology and epidemiology forecasts, clinical trials database based reports, country insights, market and opportunity assessment reports are few among many other offerings at affordable prices. We assure quality with team work and we collaboratively work with a wide range of organizations (KOLs) to garner valuable key insights. Vast & tailor made databases, healthcare specific global coverage, and expertise making us one of the unique consulting service providers in the world.

Filter
Title Search
1 - 25 of 56 Products Sort by Display
Seborrheic Dermatitis - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035550
Published
November 6, 2021
Content info
210 Pages
Price
USD 7000
Sample available
Nevoid Basal Cell Carcinoma Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035549
Published
November 2, 2021
Content info
175 Pages
Price
USD 7000
Sample available
Angelman Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035548
Published
October 29, 2021
Content info
205 Pages
Price
USD 7000
Sample available
Non-Alcoholic Steatohepatitis - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035547
Published
October 26, 2021
Content info
180 Pages
Price
USD 7000
Sample available
Systemic Scleroderma (Sclerosis) - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035546
Published
October 22, 2021
Content info
155 Pages
Price
USD 7000
Sample available
Primary Hyperoxaluria Type 1 - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035545
Published
October 19, 2021
Content info
170 Pages
Price
USD 7000
Sample available
Rett Syndrome - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035544
Published
October 15, 2021
Content info
130 Pages
Price
USD 7000
Sample available
Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035543
Published
October 12, 2021
Content info
325 Pages
Price
USD 11000
Sample available
Traumatic Brain Injury - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035542
Published
October 8, 2021
Content info
275 Pages
Price
USD 7000
Sample available
Erythromelalgia - Epidemiology Based Current (2020) and Forecasted (Till 2030) Market Values, Competitor New Drugs Pricing Strategies, Deal worth Assessments, r-NPV and Pipeline Drugs Analytics H2 2021
Published by
GervanoRA Data Services LLP
Product code
1035541
Published
October 5, 2021
Content info
132 Pages
Price
USD 7000
Sample available
Acute Myeloid Leukemia - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024215
Published
August 16, 2021
Content info
250 Pages
Price
USD 7000
Sample available
Type 1 Diabetes (T1D) - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024247
Published
August 11, 2021
Content info
300 Pages
Price
USD 7000
Sample available
Chronic Obstructive Pulmonary Disease (COPD) - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024246
Published
August 11, 2021
Content info
265 Pages
Price
USD 7000
Sample available
Osteoarthritis (OA) - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024245
Published
August 11, 2021
Content info
287 Pages
Price
USD 7000
Sample available
Chronic Kidney Disease - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024244
Published
August 11, 2021
Content info
235 Pages
Price
USD 7000
Sample available
Stimulant Abuse Deterrents - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024243
Published
August 11, 2021
Content info
246 Pages
Price
USD 11000
Sample available
Cannabidiol (CBD) Drugs - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024242
Published
August 11, 2021
Content info
250 Pages
Price
USD 11000
Sample available
Liver Cirrhosis - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024241
Published
August 11, 2021
Content info
225 Pages
Price
USD 7000
Sample available
Inflammatory Bowel Diseases - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024240
Published
August 11, 2021
Content info
310 Pages
Price
USD 7000
Sample available
Intraocular Lenses (IOLs): Pipeline Analytics, Cataract Burden, Cataract Epidemiology & Epidemiology Forecast and Deals Activity from 2010 to 2021
Published by
GervanoRA Data Services LLP
Product code
1024239
Published
August 11, 2021
Content info
55 Pages
Price
USD 7000
Sample available
Abuse Deterrents - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024238
Published
August 11, 2021
Content info
248 Pages
Price
USD 11000
Sample available
Cystic Fibrosis - Deals Analytics Report, 2010 to 2021
Published by
GervanoRA Data Services LLP
Product code
1024237
Published
August 11, 2021
Content info
60 Pages
Price
USD 7000
Sample available
Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H2 2021
Published by
GervanoRA Data Services LLP
Product code
1024236
Published
August 11, 2021
Content info
103 Pages
Price
USD 7000
Sample available
Amyotrophic Lateral Sclerosis - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024235
Published
August 11, 2021
Content info
215 Pages
Price
USD 7000
Sample available
Acute Kidney Injury - Current & Forecasted Market Opportunities, Epidemiological Studies, Market Dynamics, Pipeline Analytics and r-NPV Analysis
Published by
GervanoRA Data Services LLP
Product code
1024234
Published
August 11, 2021
Content info
200 Pages
Price
USD 7000
Sample available
Compare
item is currently selected
Compare products
Delete all